Reaction

Face Injury reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,753 reports · 121 co-occurring drugs

As of the last recalculation, Face Injury appears in 3,753 FAERS reports alongside 121 co-occurring drug terms. The strongest observed disproportionality signal is EMICIZUMAB (PRR 16.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Emicizumab	36	16.3	16.4
Cenobamate	16	10.7	10.7
Calcium, Magnesium, Potassium, And Sodium Oxybates	14	9.0	9.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled	30	7.8	7.9
Captopril	12	6.9	6.9
Sodium Oxybate	76	6.5	6.5
Lubiprostone	11	6.5	6.5
Human Immunoglobulin G	23	6.2	6.2
Brivaracetam	10	6.2	6.2
Octreotide Acetate	33	6.0	6.0
Cimetidine	10	5.8	5.8
Tolterodine Tartrate	9	5.6	5.6
Lacosamide	37	5.6	5.6
Dronabinol	8	5.5	5.5
Drs. Clotrimazole	11	5.3	5.3
Family Wellness Clotrimazole	11	5.3	5.3
Clotrimazole Topical	11	5.3	5.3
Cladribine	9	5.2	5.2
Modafinil	30	5.2	5.2
Diroximel Fumarate	11	5.1	5.1
Clotrimazole	11	5.0	5.0
Riociguat	29	5.0	5.0
Rizatriptan Benzoate	9	4.9	4.9
Primidone	9	4.9	4.9
Teriparatide	96	4.8	4.8
Oxcarbazepine	28	4.8	4.8
Rabeprazole	19	4.8	4.8
Meclizine	14	4.8	4.8
Dicyclomine Hydrochloride	12	4.7	4.7
Amlodipine Besylate And Valsartan	9	4.5	4.5
Carbidopa And Levodopa	38	4.5	4.5
Selexipag	20	4.3	4.3
Meclizine Hydrochloride	15	4.3	4.3
Armodafinil	16	4.2	4.2
Carbamazepine	48	4.0	4.0
Acetaminophen, Aspirin (Nsaid) And Caffeine	12	3.9	3.9
Clobazam	17	3.9	3.9
Insulin Glulisine	7	3.8	3.8
Raloxifene Hydrochloride	10	3.8	3.8
Oxybutynin Chloride	6	3.8	3.8
Levodopa	8	3.7	3.7
Baclofen	56	3.6	3.6
Donepezil Hydrochloride	24	3.6	3.6
Ropinirole	10	3.6	3.6
Vilazodone Hydrochloride	6	3.6	3.6
Biotin	20	3.6	3.6
Cannabidiol	15	3.6	3.6
Lanreotide Acetate	5	3.5	3.5
Quinapril Hydrochloride	5	3.5	3.5
Acetaminophen, Aspirin, And Caffeine	13	3.4	3.4
Dutasteride	5	3.4	3.4
Fish Oil	55	3.4	3.4
Epoprostenol	8	3.4	3.4
Zonisamide	9	3.4	3.4
Timolol Maleate	6	3.4	3.4
Amphetamine	5	3.4	3.4
Interferon Beta-1A	112	3.3	3.3
Tizanidine	14	3.3	3.3
Vismodegib	5	3.1	3.1
Bosutinib	5	3.1	3.1
Benzonatate	9	3.0	3.0
Sildenafil	31	3.0	3.0
Dalfampridine	37	2.9	2.9
Amantadine	8	2.9	2.9
Droxidopa	11	2.8	2.8
Teriflunomide	23	2.8	2.8
Macitentan	34	2.7	2.7
Lifitegrast	8	2.7	2.7
Rotigotine	7	2.7	2.7
Budesonide, Glycopyrrolate, And Formoterol Fumarate	5	2.7	2.7
Fingolimod Hcl	41	2.6	2.6
Sildenafil Citrate	60	2.6	2.6
Icosapent Ethyl	4	2.6	2.6
Dabigatran Etexilate	36	2.6	2.6
Apixaban	31	2.6	2.6
Alpelisib	4	2.5	2.5
Miconazole Nitrate	4	2.5	2.5
Treprostinil	57	2.5	2.5
Rasagiline Mesylate	5	2.5	2.5
Dabigatran Etexilate Mesylate	32	2.5	2.5
Romosozumab-Aqqg	6	2.5	2.5
Sunitinib Malate	17	2.4	2.4
Tafamidis	5	2.4	2.4
Naltrexone	13	2.3	2.3
Interferon Beta-1B	8	2.3	2.3
Pimavanserin Tartrate	23	2.3	2.3
Buprenorphine Hydrochloride, Naloxone Hydrochloride	10	2.3	2.3
Vigabatrin	6	2.3	2.3
Ticagrelor	13	2.3	2.3
Natalizumab	71	2.2	2.2
Upadacitinib	32	2.2	2.2
Risankizumab-Rzaa	32	2.2	2.2
Ibrutinib	31	2.1	2.1
Bosentan	19	2.1	2.1
Vibegron	3	2.1	2.1
Abiraterone	5	2.0	2.0
Glecaprevir And Pibrentasvir	4	2.0	2.0
Travoprost	3	1.9	1.9
Selinexor	3	1.9	1.9
Temozolomide	7	1.8	1.8
Acalabrutinib	4	1.8	1.8
Varenicline Tartrate	26	1.8	1.8
Botulinum Toxin Type A	4	1.8	1.8
Valbenazine	8	1.8	1.8
Rimegepant Sulfate	4	1.8	1.8
Dimethyl Fumarate	38	1.7	1.7
Suvorexant	4	1.7	1.7
Hydrocodone Bitartrate And Acetaminophen	17	1.7	1.7
Glatiramer Acetate	18	1.7	1.7
Ravulizumab	4	1.6	1.6
Ambrisentan	36	1.6	1.6
Onabotulinumtoxina	21	1.5	1.5
Ofatumumab	9	1.5	1.5
Sacubitril And Valsartan	30	1.4	1.4
Ixazomib	7	1.3	1.3
Peginterferon Beta-1A	3	1.3	1.3
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	7	1.3	1.3
Abaloparatide	6	1.1	1.1
Galcanezumab-Gnlm	6	1.1	1.1
Sarilumab	5	1.0	1.0
Adapalene	3	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.